Denosumab (Prolia)

denosumab · Amgen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Denosumab (Prolia), covering 2024-09-19 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2) [Phase 4]